Abstract
Astrocytomas with anaplastic foci and glioblastoma multiforme have a poor prognostic outlook despite multiple efforts of aggressive combined integrated multi-modality treatment. In 1994, the American Cancer Society estimates that 17 500 new cases of brain and central nervous system tumors will be diagnosed with a projected death rate of 12600 (Boring et al. 1994). Of these new cases, approximately 7000 or 40% will be malignant astrocytomas and the majority of these will be high grade gliomas of the brain- 4200 to 5560 (Mahaley et al. 1989). Standard treatment is generally surgical resection followed by conventionally fractionated external beam radiotherapy to approximately 60–65 Gy in 6–7 weeks of treatment. However, survival for these patients remains poor, with median survival of 42 weeks in large cooperative trial studies with conventional treatment (Walker et al. 1978). The addition of chemotherapy to the management of high grade gliomas has been of little benefit in altering this bleak outlook for management.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Bernstein M, Gutin PH (1981) Interstitial irradiation of brain tumors: a review. Neurosurgery 9(6)
Bloomer WD, Adelstein SJ (1981) Iodine-125 cytotoxicity: implications for therapy and estimation of radiation risk. Int J Nucl Med Biol 8: 171–178
Boring CC, Squires TS, Tong T, Montgomery S (1994) Cancer Statistics, 1994. CA 44: 7–26
Bradley EW, Chan PC, Adelstein SJ (1975) The radiotoxicity of iodine-125 in mammalian cells. I. Effects on the survival curve of radioiodine incorporated into DNA. Radiat Res 64: 555
Brady LW, Miyamoto C, Woo DV, Rackover M, Emrich J, Bender H, Dadparvar S, Steplewski Z, Koprowski H et al. (1992) Malignant astrocytomas treated with iodine-125 labeled monoclonal antibody 425 against epidermal growth factor receptor: a phase II trial. Int J Radiat Oncol Biol Phys 22: 225–230
Chang CH, Horton J, Schoeffeld D et al. (1983) Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas: a Joint Radiation Therapy Oncology and Eastern Cooperative Oncology Group study. Cancer 52: 997–1007
Epenetos AA, Coutenay-Luck N, Pickering D, Hooker G, Durbin H, Lavender JP, McKenzie CG (1985) Antibody guided irradiation of brain glioma by arterial infusion of radioactive monoclonal antibody against epidermal growth factor receptor and blood group A antigen. Br Med J 290: 1463–1466
Fine HA, Dear KGB, Loeffler JS, Black PMCL, Canellos GP (1993) Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer 71: 2585–2597
Horiot JC, Van den Bogaert W, Ang KK et al. (1988) European organization for research on treatment of cancer trials using radiotherapy with multiple fractions per day. Front Radiat Ther Oncol 22: 149–161
Hosobuchi Y, Phillips TL, Stupar TA, Gutin PH (1980) Interstitial brachytherapy of primary brain tumors. J Neurosurg 53: 613–617
Kalofonos HP, Pawlikowska TR, Hemingway A, Courtenay-Luck N, Dhokia B, Snook D, Sivolapenko GB, Hooker GR et al. (1989) Antibody guided diagnosis and therapy of brain gliomas using radiolabeled monoclonal antibodies against epidermal growth factor receptor and placental alkaline phosphatase. J Nucl Med 30: 1636–1645
Koch C, Burki HJ (1975) The oxygen-enhancement ratio for reproductive death induced by 3H or iodine-125 damage in mammalian cells. Int J Radiat Biol Stud Phys Chem Med 28 (5): 414–425
Laperriere NJ, Bernstein M (1994) Radiotherapy for brain tumors. CA 44: 96–108
Loeffler JS, Alexander E III, Wen PY, Shea WM (1990) Results of stereotactic brachytherapy used in the initial management of patients with glioblastoma. J Natl Cancer Inst 82: 1918–1921
Mahaley SM, Mettlin C, Natarajan N et al. (1989) National survery of patterns of care for brain tumor patients. J Neurosurg 71: 826–836
Murthy U, Basu A, Rodeck U, Herlyn M, Ross A, Das M (1987) Domain-specificity and antagonistic properties of a new monoclonal antibody to the EGF-receptor. Arch Biochem Biophys 252: 549–560
Nelson DF, Curran WJ Jr, Scott C, Nelson JS, Weinstein AS et al. (1993) Hyperfractionated radiation therapy and bis-chlorethyl nitrosourea in the treatment of malignant glioma — possible advantage observed at 72 Gy in 1.2 Gy BID fractions: report of the Radiation Therapy Oncology Group, protocol 8302. Int J Radiat Oncol Biol Phys 25: 193–207
Qin DX, Zheng R, Tang J, Li JX, Hu YH (1990) Influence of radiation on the blood brain barrier and optimum time of chemotherapy. Int J Radiat Oncol Biol Phys 19: 1507–1510
Schultz CJ, Geard CR (1990) Radioresponse of human astrocytic tumors across grade as a function of acute and chronic irradiation. Int J Radiat Oncol Biol Phys 19: 1397–1403
Simpson WJ, Platts ME (1976) Fractionation study in the treatment of glioblastoma multiforme. Int J Radiat Oncol Biol Phys 1: 639–644
Sneed PK, Gutin PH, Stauffer PR, Phillips TL, Prados MD, Weaver KA, Suen S, Lamb SA, Ham B, Ahn DK, Lamborn K, Larson DA, Wara WM (1992) Thermoradiotherapy of recurrent malignant brain tumors. Int J Radiat Oncol Biol Phys 23: 853–861
Walker MD, Alexander E, Hunt WE et al. (1978) Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas: a cooperative clinical trial. J Neurosurg 49: 333–343
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer-Verlag Berlin · Heidelberg
About this paper
Cite this paper
Miyamoto, C.T. et al. (1996). The Use of Epidermal Growth Factor Receptor-425 Monoclonal Antibodies Radiolabeled with Iodine-125 in the Adjuvant Treatment of Patients with High Grade Gliomas of the Brain. In: Sautter-Bihl, ML., Bihl, H., Wannenmacher, M. (eds) Systemic Radiotherapy with Monoclonal Antibodies. Recent Results in Cancer Research, vol 141. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-79952-5_13
Download citation
DOI: https://doi.org/10.1007/978-3-642-79952-5_13
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-79954-9
Online ISBN: 978-3-642-79952-5
eBook Packages: Springer Book Archive